Cancer Drugs to Get Cheaper by Up to 70% as Government Caps Margins on 137 Medicines

The government has capped trade margins at 30% on 137 anti-cancer medicines, aiming to reduce prices by up to 70% and ease treatment costs for patients.

Cancer Medicines to Become Cheaper as Government Caps Trade Margins on 137 Drugs

Government Announces Relief for Cancer Patients

In a significant step towards making cancer treatment more affordable, the government has introduced a 30% cap on trade margins for 137 anti-cancer medicines. The move is expected to reduce the prices of several medicines by up to 70%, offering potential financial relief to patients and their families.

The measure has been introduced by the National Pharmaceutical Pricing Authority (NPPA), which operates under the Ministry of Chemicals and Fertilizers. Its objective is to limit excessive margins across the medicine distribution network and ensure that patients have access to essential cancer treatments at more reasonable prices.

Cancer treatment can involve substantial expenses, particularly when patients require expensive medicines over an extended period. By regulating trade margins, the government aims to reduce the financial burden associated with these treatments and improve affordability.

Revised Cancer Medicine Prices to Take Effect on November 9

The revised prices are scheduled to come into effect on November 9, 2026, according to the announcement provided.

Drug manufacturers will be required to notify the NPPA of their revised prices within seven days of the relevant Gazette notification. They must also publish updated price lists on their official websites and provide the revised information to hospitals, pharmacies and other retailers.

Hospitals and medical retailers will need to implement the applicable reduced prices from the effective date and display the updated rates prominently.

These requirements are intended to improve price transparency and help ensure that patients benefit from the revised pricing arrangements. Consumers should check the applicable price of their prescribed medicines after the new rates take effect.

Which Anti-Cancer Medicines Are Covered?

The new measure covers 137 non-scheduled anti-cancer medicines used in the treatment of different types of cancer.

The medicines include several therapies used in specialised cancer care, including immunotherapy drugs that help the body's immune system recognise and fight cancer cells.

Key medicines mentioned in the announcement include:

• Pembrolizumab: An immunotherapy medicine used for certain cancers, depending on the approved indication.

• Durvalumab: An immunotherapy treatment prescribed for specific cancer types.

• Osimertinib: A targeted therapy used for certain forms of lung cancer.

• Bevacizumab: A medicine used in the treatment of several cancers, including certain colorectal, ovarian and cervical cancers.

• Denosumab: A medicine used for particular indications involving bone health and cancer-related complications.

• Pegfilgrastim: A medicine used to help prevent or reduce the risk of neutropenia associated with certain cancer treatments.

The reported list also includes immunotherapy medicines used against more than 20 types of cancer.

The actual price reduction will depend on the specific medicine, brand and revised price notified under the applicable order. Patients should consult their doctors or pharmacists before making any changes to their treatment.

How Patients Can Check the Revised Medicine Prices

Patients and their families can use government resources to check the applicable prices of medicines covered by the initiative.

The NPPA's official website provides information on pharmaceutical pricing orders and notified medicine prices. Consumers can also use the government's Pharma Sahi Daam mobile application to look up medicine prices.

After the revised rates take effect, patients should compare the listed prices with the amounts charged by pharmacies and hospitals.

If a medicine appears to be priced above the applicable notified rate, consumers can request an explanation and refer to the official NPPA price information.

Checking prices through reliable government sources can help patients understand their medicine expenses and identify potential discrepancies.

Earlier NPPA Initiative Reduced Prices by Up to 90%

The latest decision builds on an earlier initiative introduced by the NPPA in 2019.

During that exercise, trade margins on 42 anti-cancer medicines were capped at 30%. According to the information provided, the measure resulted in price reductions of up to 90% across 526 medicine brands.

The latest expansion seeks to extend similar pricing controls to a larger group of anti-cancer medicines.

The initiative follows recommendations from an expert committee under the Directorate General of Health Services. Its broader objective is to improve affordability while strengthening oversight of medicine prices across the distribution chain.

The earlier exercise provides context for the government's continued efforts to address the high cost of cancer medicines.

What the Price-Cap Decision Means for Patients

The expanded trade-margin cap could help reduce medicine expenses for patients requiring costly cancer therapies. Lower prices may also ease some of the financial pressure on families managing repeated consultations, diagnostic tests and long-term treatment.

However, the reported reduction of up to 70% should not be interpreted as a uniform price cut across all 137 medicines. Actual savings will vary depending on each drug's existing price and the applicable revised rate.

Patients should also remember that affordability measures do not replace medical advice. Treatment decisions, including the choice of medicines and dosages, must remain under the supervision of qualified healthcare professionals.

Conclusion

The government's decision to cap trade margins on 137 anti-cancer medicines marks an important step towards making cancer treatment more affordable in India. With revised prices scheduled from November 9, 2026, patients should check official NPPA listings and pharmacy prices to understand the savings applicable to their prescribed medicines.